QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
114 views
Using public data from GTEx (normal tissue), GEO, cancer collections and more, you’ll learn how to use Omicsoft Lands to:
• Investigate a drug target or biomarker expression across different normal tissues, disease conditions, treatments and more
• Correlate expression of two or more genes
• Identify a list of genes or biomarkers specific to treatment, disease, normal tissue, cell type and more
Using findings from peer-reviewed publications and other sources, attendees we’ll explore with you how to use QIAGEN IPA to:
• Study the impact of targeting a gene/protein on different toxicological and biological functions
• Derive tox findings for a gene of interest from QIAGEN IPA’s knowledgebase
• Identify and study toxicity-related pathways, regulators and functions for an internal dataset or a public dataset
• Compare different drug treatments, other conditions or multi-omics data for novel discoveries
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Discoveries from public immuno-oncology studies using Omicsoft and Ingenuity Pathway Analysis
This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors investigation in context of biomarkers, drug targets and pathways using...
This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors in the context of biomarkers, drug targets and pathways
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Biomarker discovery and disease pathology investigation using OmicSoft and Ingenuity Pathway...
In this training, attendees will learn how to harness curated ‘omics...